Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05452720 · ClinicalTrials.gov registry record · NA
MASA Valve Early Feasibility Study
A NA study of Tetrology of Fallot and Transposition of Great Vessels, sponsored by PECA Labs.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 5
- Study locations
NCT05452720 is a NA study of Tetrology of Fallot and Transposition of Great Vessels that is actively recruiting participants, run by PECA Labs. The registered enrollment target is 10 participants, below the 89-participant average among 3 other Tetrology of Fallot trials with a reported enrollment target (89% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT05452720, a NA study of Tetrology of Fallot and Transposition of Great Vessels, is actively recruiting participants, sponsored by PECA Labs.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 5
- Study locations
Study Summary
The MASA Valve Early Feasibility Study (MVEFS) multi-site interventional clinical trial within the United States of America with each center following a common protocol.The objective of the trial is to evaluate the safety and probable benefit of MASA Valve in the indicated subset of patients requiring Right Ventricular Outflow Tract Reconstruction (RVOTR). As an early feasibility study, the purpose is determine the feasibility of success of the device in order to gather early data towards a future pivotal study and/or regulatory clearance submission.
Conditions Studied
Interventions
- DEVICE Surgical Right Ventricular Outflow Tract Reconstruction
Study Locations (5)
Illinois
- OSF Childrens Hospital of Illinois - Peoria
Massachusetts
- Boston Childrens Hospital - Boston
Ohio
- Cincinnati Children's Hospital - Cincinnati
Pennsylvania
- Childrens Hospital of Philadelphia - Philadelphia
Texas
- Childrens Medical Center Dallas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2023-05-18 |
| Est. Completion | 2028-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05452720
The ClinicalTrials.gov registry entry for NCT05452720 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 89-participant average among 3 other Tetrology of Fallot trials with a reported enrollment target (89% lower). The listed sponsor is PECA Labs, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Tetrology of Fallot appearing as the primary indexed condition, and to 1 intervention - of which Surgical Right Ventricular Outflow Tract Reconstruction is the first listed.
NCT05452720 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Illinois, Massachusetts, Ohio.
Frequently Asked Questions
What is clinical trial NCT05452720 about?
NCT05452720 is a clinical study titled "MASA Valve Early Feasibility Study". The MASA Valve Early Feasibility Study (MVEFS) multi-site interventional clinical trial within the United States of America with each center following a common protocol.The objective of the trial is to evaluate the safety and probable benefit of MASA Valve in the indicated subset of patients requiri...
What is the current status of trial NCT05452720?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2023-05-18. Estimated completion is 2028-04-01.
What conditions does trial NCT05452720 study?
This clinical trial studies the following conditions: Tetrology of Fallot, Transposition of Great Vessels, Pulmonary Stenosis, Truncus Arteriosus, Pulmonary Atresia.
What interventions are being tested in trial NCT05452720?
The interventions under investigation include: Surgical Right Ventricular Outflow Tract Reconstruction (DEVICE).
Who is sponsoring clinical trial NCT05452720?
This trial is sponsored by PECA Labs, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05452720 being conducted?
This trial has 5 study locations across Illinois, Massachusetts, Ohio, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tetrology of Fallot
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.